Clinical Trial Update: Composite Ratios Boost CRP's Power in Monitoring Ulcerative Colitis.

View source ↗

Summary

A clinical trial update reports that composite ratios involving C-reactive protein improve monitoring of ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: Benha University | Conditions: Ulcerative Colitis | Status: COMPLETED